AUTHORS
Meng Zhang, Hengwei Wu, MD2, XinYi Lai3, Meihua Zhu4, Yunfei Liu5, Mengmeng Huang, PhD6, Xiangjun Zeng, MD7, Yanmin Zhao, MD8, Fang Ye9, He Huang, MD, PhD10
AFFILIATIONS
1 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
2 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
3 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
4 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
5 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
6 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
7 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
8 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
9 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
10 Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
ABSTRACT
Background: Acute graft-versus-host disease (aGVHD) is commonly defined by target-organ injury, yet impaired hematopoiesis and delayed immune reconstitution are major complications after allogeneic hematopoietic stem cell transplantation. GVHD can damage the bone marrow (BM) niche and suppress B lymphopoiesis, but how it reshapes erythroid differentiation across BM, spleen and liver remains poorly understood.
Methods: Conditioned BALB/c mice received C57BL/6 BM alone as transplantation controls or the same BM plus donor T cells to induce aGVHD. Flow cytometry and histopathology were performed on days 7, 14 and 21 after transplantation. At the established disease stage on day 14, we performed single-cell RNA sequencing of BM, spleen and liver and high-resolution spatial transcriptomics (Stereo-seq) of spleen and liver. Erythroid cells were integrated across the three tissues and analyzed using compositional, pathway-scoring, pseudotime and spatial approaches.
Results: CD3+ T cells increased in all three organs during aGVHD, and more than 90% of recovered T cells were donor derived. In BM, expansion of T-cell states coincided with contraction of B-cell states. Reduced Ighm, Ly6d, Vpreb3, Bach2 and Ebf1 programs and increased Ccl5, Ifitm1/6 and Tox expression indicated a shift from B lymphopoiesis toward donor T-cell-associated inflammation. Flow cytometry independently confirmed reduced BM B cells and increased T cells. In spleen, white-pulp organization and B-cell-rich regions were disrupted. The liver lacked overt histological injury but showed increased representation of hepatic stellate-cell states, induction of the acute-phase and stress genes Saa1/2/3 and Mt1/2, and reduction of hepatocyte metabolic and iron-regulatory programs, including Hamp and Cyp3a11.
Integrated analysis resolved six erythroid states: megakaryocyte–erythroid progenitors, early erythroblasts, proliferating erythroblasts, stress-associated erythroid cells, MT-high erythroblasts and mature erythrocytes. Compared with controls, aGVHD samples showed increased representation of stress-associated erythroid cells and MT-high erythroblasts, with relative contraction of mature erythrocytes and progenitor or proliferative states. These states were organ-partitioned: spleen contributed prominently to progenitor and early erythroblast states, liver was enriched in stress-associated and later-pseudotime states, and BM preferentially contributed early or intermediate and MT-high states.
Pseudotime analysis inferred two erythroid differentiation paths. Control cells were preferentially represented in terminal states along a conventional maturation-associated path, whereas aGVHD cells were redistributed toward late states along an alternative stress-associated path. The latter showed dynamic changes in erythroid differentiation and maturation scores together with cytokine-signaling and immune-receptor programs. Stress-associated erythroid cells in aGVHD upregulated Fth1, Gpx4 and Mgst3 and were enriched for oxidative phosphorylation, aerobic respiration and mitochondrial ATP synthesis, consistent with enhanced oxidative-metabolic, iron-handling and antioxidant adaptation. Reactive-oxygen-species biosynthesis and innate immune-response programs were reduced. In spleen, spatial transcriptomics showed increased representation of erythroid-progenitor-enriched regions within the disrupted red pulp adjacent to T-cell-rich inflammatory areas, associating erythroid remodeling with the local alloimmune microenvironment.
Conclusions: aGVHD was associated with coordinated hematopoietic remodeling across BM, spleen and liver rather than isolated BM suppression. BM B-lymphopoietic failure coincided with an altered erythroid response characterized by splenic progenitor enrichment, hepatic accumulation of stress-adapted erythroid states and oxidative-metabolic and iron-handling reprogramming. These findings define an organ-partitioned hematopoietic response to aGVHD and provide a framework for investigating cytopenias and incomplete immune recovery after allogeneic transplantation.
DISCLOSURES
Meng Zhang: No relevant conflicts of interest to declare.